Back to
BlackRock Finance, Inc.
JAZZ3 quarters
Position history for
BlackRock Finance, Inc.'s holdings in Jazz Pharmaceuticals Public Limited Company
As of its last 13F, for Q2 2024, BlackRock Finance held 6,145,758 shares of JAZZ (Jazz Pharmaceuticals Public), worth $655.9M. It reduced the position by 924,162 shares (-13.1%) from Q1 2024. BlackRock Finance held JAZZ from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
$655.9M
Current Shares
6.1M
Total Value Change
-$212M
Total Shares Change
-910,274
Quarter-by-Quarter History
Other major holders of JAZZ: BlackRock, Inc., FMR LLC, VANGUARD GROUP INC